PetMed Express Reports Board and Executive Compensation Changes

Ticker: PETS · Form: 8-K · Filed: 2024-09-27T00:00:00.000Z

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

Related Tickers: PETS

TL;DR

PETS board shake-up and exec pay changes filed today.

AI Summary

PetMed Express, Inc. filed an 8-K on September 27, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing indicates a departure of directors and the election of new directors, alongside updates to the compensatory arrangements for certain officers. Specific details regarding the individuals involved and the exact nature of the compensation changes were not fully elaborated in the provided text but are central to this report.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence and stock performance.

Risk Assessment

Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may affect future performance or strategy.

Key Players & Entities

FAQ

What specific changes were made to the board of directors of PetMed Express, Inc.?

The filing indicates the departure of directors and the election of new directors, though specific names and dates of these changes are not detailed in the provided text.

What are the details of the compensatory arrangements for certain officers mentioned in the filing?

The filing states that there are updates to the compensatory arrangements of certain officers, but the specific details of these arrangements are not provided in the excerpt.

When was this Form 8-K filed with the SEC?

This Form 8-K was filed on September 27, 2024.

What is the principal executive office address for PetMed Express, Inc.?

The principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.

What is the fiscal year end for PetMed Express, Inc.?

The fiscal year end for PetMed Express, Inc. is March 31.

From the Filing

0001040130-24-000110.txt : 20240927 0001040130-24-000110.hdr.sgml : 20240927 20240927161044 ACCESSION NUMBER: 0001040130-24-000110 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240927 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240927 DATE AS OF CHANGE: 20240927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28827 FILM NUMBER: 241334962 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20240927.htm 8-K pets-20240927 0001040130 FALSE 0001040130 2024-09-27 2024-09-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  September 27, 2024 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On September 27, 2024, the Board of Directors of PetMed Express, Inc. (the “Company”) adopted the PetMed Express, Inc. 2024 Inducement Incentive Plan (the “Inducement Plan”) pursuant to which the Company reserved 350,000 shares of common stock, par value $0.0001 per share, of the Company’s common stock (subject to the adjustment provisions of the Inducement Plan) for the issuance of equity awards granted under the Inducement Plan. The Inducement Plan was adopted without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Stock Market

View on Read The Filing